Immune checkpoint inhibitor-associated diabetic ketoacidosis induced by cadonilimab: a case report and literature review

Immune checkpoint inhibitors (ICIs) significantly improve prognosis and survival outcomes in cancer patients by enhancing immune function, thereby providing new therapeutic hope for cancer patients. However, with the widespread clinical application of ICIs, an increasing number of immune-related adv...

Description complète

Détails bibliographiques

Auteurs principaux:	Yuchen Jiang, Yu Cui, Dan Su, Hao Yang, Xi Chen, Xiaodan Qian, Lidan Tang, Shan Xu
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2026-04-01
Collection:	Frontiers in Endocrinology
Sujets:	cadonilimab case report diabetic ketoacidosis immune checkpoint inhibitor induced type 1 diabetes mellitus (ICI-T1DM) literature review
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fendo.2026.1819809/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!